The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8609622, 9 ID: ALA3966902
Chembl Id: CHEMBL3966902
PubChem CID: 74982897
Max Phase: Preclinical
Molecular Formula: C25H25FO6S
Molecular Weight: 472.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1Cc1ccc(-c2ccc(F)cc2)s1
Standard InChI: InChI=1S/C25H25FO6S/c1-14-2-5-17(25-23(30)21(28)22(29)24(12-27,32-25)13-31-25)10-16(14)11-19-8-9-20(33-19)15-3-6-18(26)7-4-15/h2-10,21-23,27-30H,11-13H2,1H3/t21-,22-,23+,24+,25?/m0/s1
Standard InChI Key: GMWMRLJSWBOCQA-ILRLDQMXSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.53Molecular Weight (Monoisotopic): 472.1356AlogP: 2.48#Rotatable Bonds: 5Polar Surface Area: 99.38Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.99CX Basic pKa: ┄CX LogP: 3.73CX LogD: 3.73Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: 0.44
References 1. (2013) C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof,